Necrosis or disintegration of skeletal muscle often followed by myoglobinuria.
| Excerpt | Reference |
|---|
| "Rhabdomyolysis is an uncommon adverse effect associated with lovastatin therapy." | ( Mueller, BA; Wallace, CS, 1992) |
| "Rhabdomyolysis is a well-documented and potentially dangerous side effect of lovastatin therapy." | ( Sylvain-Moore, H; Worden, JP, 1991) |
| "Rhabdomyolysis is a common complication of cocaine use, and muscle symptoms fail to predict its development." | ( Krause, GS; Todd, K; Welch, RD, 1991) |
| "Subclinical rhabdomyolysis is a common finding in the hyperosmolal state." | ( Abramovici, M; Singhal, PC; Venkatesan, J, 1990) |
| "Rhabdomyolysis is the principal mechanism underlying PPD systemic toxicity; it is, in particular, responsible for the renal failure observed." | ( Bourquia, A; Jabrane, AJ; Ramdani, B; Zaid, D, 1988) |
| "Rhabdomyolysis is a potentially lethal syndrome that psychiatric patients seem predisposed to develop." | ( Alvarez, WA; Freinhar, JP; Johnson, SB, 1986) |
| "Rhabdomyolysis is usually known to the anaesthetist, who may be confronted with this acute, life-threatening complication during anaesthesia." | ( Abbrederis, K; Gattringer, C; Greil, R, 1985) |
| "Rhabdomyolysis is a rarely reported complication of antipsychotic drug-induced dystonia." | ( Cavanaugh, JJ; Finlayson, RE, 1984) |
| "Exertional rhabdomyolysis is a myopathy of unknown pathophysiology." | ( Cordovez, G; Linares, N; López, JR; Terzic, A, 1995) |
| "Rhabdomyolysis is a clinical disorder arising from skeletal muscle injury." | ( Becker, BN; Ismail, N, 1994) |
| "Drug induced rhabdomyolysis is common, particularly with HMG Coenzyme A reductase inhibitors." | ( de Groote, P; Decoulx, E; Ducloux, G; Mahieux, G; Millaire, A, 1993) |
| "Rhabdomyolysis is an unusual complication following infection with influenza B virus." | ( Knutsen, AP; Lynch, R; Paletta, CE, 1993) |
| "Rhabdomyolysis is thought to result from compromised vascular supply to dependent muscles, due to prolonged pressure during long periods of depressed consciousness and immobility." | ( Korzets, Z; Schneider, I; Shay, R, 1995) |
| "Exercise-induced rhabdomyolysis is a frequent event occurring after severe forms of exercise." | ( Carrillo, EH; Heniford, BT; Klodell, CT; Pokorny, R, 1996) |
| "VAHS complicated by rhabdomyolysis is very rare, and we think this case is full of suggestions." | ( Koike, T; Koizumi, K; Nishio, M; Ozutusmi, K; Sato, N; Sawada, K; Shibata, S; Yamaguchi, M; Yasukouchi, T; Yokoyama, K, 1996) |
| "Acute rhabdomyolysis is a rare complication in patients with status asthmaticus receiving mechanical ventilation." | ( Eisenhuber, E; Kramer, L; Madl, C; Ratheiser, K; Zauner, C, 1996) |
| "The occurrence of rhabdomyolysis is one of the rare side-effects of the cholesterol-lowering agent simvastatin." | ( Du Buf-Vereijken, PW; Spooren, PF; van Doormaal, JJ; van Puijenbroek, EP, 1996) |
| "Rhabdomyolysis is a serious but rare side effect of lamivudin treatment." | ( Mendila, M; Schmidt, RE; Stoll, M; Walter, GF, 1997) |
| "Rhabdomyolysis is a condition affecting body homeostasis that results from impaired supply of muscles with energy, nutritional factors and blood." | ( Sułowicz, W; Szumilak, D; Walatek, B, 1998) |
| "Rhabdomyolysis is caused by the lysis and necrosis of muscle due to direct or indirect injury, high fever, ischaemia, hypoxia or enzyme defects." | ( Nihei, Y; Sawada, Y; Yotsuyanagi, T, 1998) |
| "The development of rhabdomyolysis is increased when the HMG-CoAs are used concurrently with certain other medications, specifically gemfibrozil and macrolide antibiotics." | ( Freeman, NJ; Landesman, KA; Stozek, M, 1999) |
| "Nontraumatic rhabdomyolysis is an important but under-recognized cause of acute renal failure." | ( Bambery, P; Jha, V; Muthukumar, T; Sakhuja, V; Sud, A; Wanchoo, A, 1999) |
| "Rhabdomyolysis is a common cause of acute renal failure (ARF) associated with drug misuse." | ( Deighan, CJ; Harden, P; McLaughlin, KJ; Wong, KM, 2000) |
| "In Quarter Horses, rhabdomyolysis is commonly due to a glycogen storage disorder, PSSM, and is readily expressed in untrained horses." | ( de la Corte, F; Gallant, EM; Lentz, L; MacLeay, JM; Mickelson, JR; Valberg, SJ, 1999) |
| "Although rhabdomyolysis is an uncommon disorder, especially in children, it can present as a severe, life-threatening event." | ( Johnston, HM; Ng, YT, 2000) |
| "Rhabdomyolysis is one of the side effects of these drugs." | ( Dabrowska, M; Duda-Król, W; Jórasz, I; Kusz-Rynkun, A; Polubiec, A, 2000) |
| "Rhabdomyolysis is a rare complication of theophylline intoxication." | ( Hippius, M; Hoffmann, A; Pfeifer, R; Teweleit, S, 2001) |
| "Rhabdomyolysis is one of the reported complications of isoniazid poisoning, but relevant data are limited." | ( Corte-Maramba, NP; Makalinao, IR; Panganiban, LR, 2001) |
| "Rhabdomyolysis is a rare but potentially fatal complication associated with the use of cholesterol synthesis inhibitors (statins)." | ( Banga, JD, 2001) |
| "Rhabdomyolysis is a relatively rare, not always diagnosed cause of acute renal failure (ARF)." | ( Kraśniak, A; Lonak, H; Miłkowski, A; Ochmański, W; Sułowicz, W; Sydor, A; Szumilak, D; Szymczakiewicz-Multanowska, A; Walatek, B; Wójcikiewicz, T, 2002) |
| "Rhabdomyolysis is an unusual complication of hematopoietic stem cell transplantation (HSCT)." | ( Aoyama, Y; Hino, M; Makita, K; Nakamae, H; Ohta, K; Shima, E; Sugano, Y; Takubo, T; Tatsumi, N; Yamamura, R; Yamane, T; Yasuda, S, 2002) |
| "Severe cases of rhabdomyolysis are rarer, but may have a significant mortality." | ( Hodel, C, 2002) |
| "Rhabdomyolysis is one of the perioperative complications in patients with Duchenne's muscular dystrophy (DMD)." | ( Furuya, H; Kawaguchi, M; Kitaguchi, K; Sakamoto, T; Sha, K; Shimokawa, M; Takahashi, H, 2002) |
| "Rhabdomyolysis is a common disorder, which may result from a large variety of diseases, trauma, or toxic insults to skeletal muscle." | ( Rupert, SA, 2002) |
| "Rhabdomyolysis is an uncommon complication associated with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors." | ( Butler, KL; Lucas, RA; Pepper, JM; Rocco, VK; Weathersby, BB, 2002) |
| "Rhabdomyolysis is an unusual complication of chemotherapy that can lead to substantial morbidity through such complications as renal failure, infections, and disseminated intravascular coagulation." | ( Frankel, SR; Truica, CI, 2002) |
| "Rhabdomyolysis is a known complication of hepatic 3-methylglutaryl coenzyme A reductase (HMG-CoA) inhibitor (statin) therapy for posttransplant hyperlipidemia, and thus monitoring for this effect is indicated." | ( Bhaloo, S; Meliton, G; Prasad, GV; Wong, T, 2002) |
| "Rhabdomyolysis is a severe and life-threatening syndrome caused by various insults to skeletal muscle, including drug-induced injury." | ( Haas, CE; Magram, Y; Mishra, A, 2003) |
| "Nontraumatic rhabdomyolysis is an uncommon adverse outcome of drug and toxin ingestion." | ( Haas, CE; Magram, Y; Mishra, A, 2003) |
| "Rhabdomyolysis is a severe adverse effect of hypolipidaemic agents such as statins and fibrates." | ( Matsuyama, K; Matzno, S; Mishima, M; Nakabayashi, T; Tanaka, H; Tazuya-Murayama, K; Uchida, T; Yasuda, S, 2003) |
| "Rhabdomyolysis is a disorder characterized by skeletal muscle injury and fatal complications at times." | ( Busiello, L; Cascella, M; De Robertis, E; Di Domenico, MG; Palmese, S; Pezza, M, 2003) |
| "Rhabdomyolysis is a potentially lethal disorder, characterized by elevated serum concentrations of creatine kinase (CK) due to skeletal muscle injury." | ( Beckers, D; Casteels, K; Van Geet, C; Wouters, C, 2003) |
| "Rhabdomyolysis is a life-threatening clinical and biochemical syndrome that results from injury to skeletal muscle." | ( Andreou, ER; Ledger, S, 2003) |
| "Rhabdomyolysis is a known, rare serious side effect of statin monotherapy and of statin-fibrate combination therapy." | ( Chang, JT; Green, L; Parks, M; Staffa, JA, 2004) |
| "Rhabdomyolysis is a rare, serious side effect of statin monotherapy and of statin-fibrate combination therapy." | ( Chang, JT; Green, L; Parks, M; Staffa, JA, 2004) |
| "Rhabdomyolysis is a rare complication when treating with slow-release bupropion for smoking cessation." | ( Bobé, F; Buil, ME; Palacios, L, 2004) |
| "Rhabdomyolysis is a rare side effect of statin therapy with an estimated incidence of 0." | ( Hartung, HP; Köller, H; Neuhaus, O; Schroeter, M, 2005) |
| "Rhabdomyolysis is a syndrome characterized by muscle necrosis and the release of intracellular muscle contents into the systemic circulation." | ( Alici, T; Colak, HB; Kursat, S, 2005) |
| "Myopathy and rhabdomyolysis are rare adverse effects of treatment with hydroxymethylglutaryl-coA reductase inhibitors." | ( Iskra, B; Kes, P; Zivko, M, 2005) |
| "Rhabdomyolysis is uncommon, but is a serious side-effect observed following statin use." | ( Magalhães, ME, 2005) |
| "Rhabdomyolysis is a recognized but uncommon side effect of statin therapy." | ( Biggs, MJ; Bonser, RS; Cram, R, 2006) |
| "Rhabdomyolysis is well known after traumatic crush injuries or ischemia involving muscles." | ( Boglia, J; Chughtai, B; Darras, F; Khan, SA; Lewis, R; Rehman, J; Samadi, DB; Sukkarieh, T; Wadhwa, NK; Waltzer, WC, 2006) |
| "Rhabdomyolysis is a syndrome of muscle necrosis and release of intracellular components into the circulation." | ( Boglia, J; Chughtai, B; Darras, F; Khan, SA; Lewis, R; Rehman, J; Samadi, DB; Sukkarieh, T; Wadhwa, NK; Waltzer, WC, 2006) |
| "Acute rhabdomyolysis is rarely reported." | ( Granier, H; Le Guen, P; Nicolas, X; Talarmin, F, 2007) |
| "Hypokalaemic rhabdomyolysis is unusual, but the association between hypokalaemia and rhabdomyolysis can be overlooked if intracellular potassium leakage normalizes serum potassium by the time of presentation." | ( Kessel, B; Kishore, B; Thurlow, V, 2007) |
| "Rhabdomyolysis is a clinical syndrome in which skeletal muscle damage and necrosis leads to the release of intracellular muscle contents, which can ultimately lead to electrolyte disturbances, renal failure and even death." | ( Beldner, M; Kraft, A; Montero, AJ; Skorupa, A, 2007) |
| "Colchicine-induced rhabdomyolysis is a rare complication, and the postulated mechanisms and risk factors for this severe complication are discussed." | ( Altman, A; Shoenfeld, Y; Szyper-Kravitz, M, 2007) |
| "Rhabdomyolysis is a rare cause of acute renal failure following laparoscopic donor nephrectomy." | ( Baldwin, DD; Baron, PW; Harper, JD; Ojogho, ON, 2007) |
| "Rhabdomyolysis is a well known side effect of statin therapy." | ( Azizi, M; Behrens, S; Hashagen, S; Nägele, H, 2007) |
| "Rhabdomyolysis is a clinical and biochemical syndrome occurring when skeletal muscle cells erupt and result in release of creatine phosphokinase (CPK), lactate dehydrogenase (LDH) and myoglobin into the interstitial space and plasma." | ( Abdollahi, M; Emami, H; Hajinasrolah, S; Pajouhmand, A; Panahandeh, R; Talaie, H; Tghaddosinezhad, M, 2007) |
| "Rhabdomyolysis is defined as a pathological condition of skeletal muscle cell damage leading to the release of toxic intracellular material into the circulation." | ( Ergen, K; Karatemiz, G; Kazancioglu, R; Kumbasar, B; Tahmaz, M; Ure, U, 2007) |
| "Rhabdomyolysis is the disintegration of striated muscles resulting in the release of muscular cell contents into the extracellular fluid." | ( Sever, MS, 2007) |
| "Rhabdomyolysis is a condition that results from many underlying etiologies and can present in a myriad of ways to the emergency physician." | ( Luck, RP; Verbin, S, 2008) |
| "Rhabdomyolysis is a potential adverse consequence of statin therapy." | ( Abuzetun, JY; Hazin, R; Porter, J; Suker, M, 2008) |
| "Rhabdomyolysis is a rare but life-threatening complication of statin therapy." | ( Al-Khayatt, MS; Brull, DJ; Campbell, VL; O'Mahony, C, 2008) |
| "Rhabdomyolysis is associated with infectious diseases in approximately 5% of cases and acute kidney injury occurs in 33-50% of cases." | ( Almeida, JP; Daher, EF; Libório, AB; Lima, RS; Santos, SQ; Silva Júnior, GB; Silva, SW; Siqueira, FJ, 2008) |
| "Although rhabdomyolysis is a rare side effect (< 1%) of olanzapine, this adverse event should be evoked when a patient with olanzapine presents with muscle pain, unexplained fatigue or weakness." | ( Cathébras, P; Guy, C; Koenig, M; Ribeyron, S, 2009) |
| "Rhabdomyolysis is an extremely rare side effect of GBP." | ( Bilgir, F; Bilgir, O; Calan, M; Kebapçilar, L; Sari, I; Yildiz, Y; Yüksel, A, 2009) |
| "Rhabdomyolysis is one of the causes of acute renal failure." | ( Hsu, BG; Lee, CJ; Lee, RP; Subeq, YM; Wu, WT; Yang, FL, 2009) |
| "Rhabdomyolysis is often associated with sepsis and gram positive bacterial pathogens are reported to be the most frequent cause of sepsis induced rhabdomyolysis." | ( Abraham, G; Bhaskar, E; Kumar, AA; Palamaner Subash Shantha, G; Swaminathan, P, 2009) |
| "Rhabdomyolysis is not common in primary hyperaldosteronism." | ( Corrales, PP; López, AH; Martínez, JJ; Meneses, AL; Oliveira, CL; Rodríguez, SA; Romero, FB, 2009) |
| "Rhabdomyolysis is a rare presentation of hypokalemia, although muscle weakness is a well known manifestation of marked hypokalemia." | ( Ahmetoğlu, A; Bahat, E; Imamoğlu, M; Karagüzel, G; Okten, A; Yildiz, K, 2009) |
| "Trimethoprim-Rhabdomyolysis is a serious, potentially life-threatening complication diagnosed when creatine phosphokinase levels exceed 1000 U/L." | ( Dickmeyer, N; Kiel, PJ; Schwartz, JE, 2010) |
| "Rhabdomyolysis is rarely reported." | ( George, P; Jhawar, M; Pawar, B, 2010) |
| "Rhabdomyolysis is a known complication of statin therapy and may be triggered by a pharmacokinetic interaction between a statin and a second medication." | ( Clarkson, MR; Conlon, PJ; Leavey, SF; Magee, CN; Medani, SA, 2010) |
| "Rhabdomyolysis is a common condition with potentially devastating complications, including acute renal failure, arrhythmias, and death." | ( Antoon, JW; Chakraborti, C, 2011) |
| "Rhabdomyolysis is a well-known complication of various drug therapies." | ( Bell, R; Gupta, A; Guron, N; Harris, M, 2012) |
| "Rhabdomyolysis is one of the causes of acute renal failure." | ( Chiu, YH; Hsu, BG; Lee, CJ; Lee, RP; Subeq, YM; Yang, FL, 2012) |
| "Rhabdomyolysis is an important cause of acute renal failure (ARF) and renal vasoconstriction is the main mechanism in the pathogenesis of ARF." | ( Cil, O; Ertunc, M; Gucer, KS; Iskit, AB; Onur, R; Ozaltin, F, 2012) |
| "Rhabdomyolysis is an uncommon event during trabectedin treatment." | ( Alfaro, V; Cartoafa, M; D'Incalci, M; Fernández-Teruel, C; Gómez, J; Grosso, F; Judson, I; Kahatt, C; Lardelli, P; Nieto, A; Roy, E; Soto-Matos, A, 2012) |
| "Rhabdomyolysis is a potentially life-threatening condition caused by a breakdown of skeletal muscle and the release of the intracellular contents into the circulatory system." | ( Care, DA; Parekh, R; Tainter, CR, 2012) |
| "Acute rhabdomyolysis is a rare but recognized side effect of atorvastatin occurring within a few weeks of initiation." | ( Fenech, ME; Mackay, JW; Myint, KS, 2012) |
| "Rhabdomyolysis is a clinical condition of potential life threatening destruction of skeletal muscle caused by diverse mechanisms including drugs and toxins." | ( Hohenegger, M, 2012) |
| "Rhabdomyolysis is a clinical condition that causes renal failure up to 40%." | ( Arı, D; Cansız, M; Gazioğlu, S; Kaynar, K; Özkan, G; Ulusoy, Ş, 2012) |
| "Rhabdomyolysis is a potentially dangerous side effect of statin drugs." | ( Chen, CL; Pan, TM, 2012) |
| "Rhabdomyolysis is a rare but serious side effect that may lead to renal failure and dangerous electrolyte abnormalities in patients with decreased hepatic clearance of atorvastatin." | ( Eshraghian, A; Kamyab, AA, 2013) |
| "Rhabdomyolysis is defined as a pathological condition of skeletal muscle cell damage leading to the release of toxic intracellular components into the circulation." | ( Begenik, H; Canbaz, ET; Emre, H; Erdur, MF; Erkoc, R; Soyoral, YU, 2012) |
| "Rhabdomyolysis is an uncommon side effect of trabectedin which is used for the second line therapy of metastatic sarcoma after anthracycline and ifosfamide failure." | ( Albano, A; Guida, M; Lorusso, V; Strippoli, S, 2013) |
| "Rhabdomyolysis is a rare, but possible, complication of combination antiretroviral therapy (cART)." | ( Coceani, M; Iapoce, R; Petersen, C; Rovai, D; Sbrana, F, 2014) |
| "Rhabdomyolysis is a rare complication of such poisoning." | ( Góis, AF; Santana, NO, 2013) |
| "Rhabdomyolysis is a very rare complication of poisoning due to tricyclic drugs." | ( Góis, AF; Santana, NO, 2013) |
| "Rhabdomyolysis is an uncommon complication of hyponatremia, reported previously only in case reports and small retrospective studies, and its underlying mechanism is controversial." | ( Amar, E; Dolkart, O; Finn, T; Peled, M; Zeltser, D, 2014) |
| "Rhabdomyolysis is a leading cause of acute kidney injury." | ( Gao, X; Gu, H; Sun, X; Yang, M; Zhao, B; Zhao, X, 2014) |
| "Rhabdomyolysis is a potentially lethal clinical syndrome that results from the necrosis of muscle fibres, with the passage of its components into the circulation, and is underdiagnosed in primary care." | ( Alvarez-Cordovés, MM; Mirpuri-Mirpuri, PG; Pérez-Monje, AJ, 2012) |
| "Rhabdomyolysis is a rare phenomenon that may be challenging to recognize in an emergency setting." | ( Lionte, C; Petrov, M; Yatsynovich, Y, 2015) |
| "Rhabdomyolysis is frequently complicated by multiple electrolyte abnormalities, including hyperkalemia, hyperphosphatemia, and hypo/hypercalcemia." | ( Hechanova, LA; Sadjadi, SA, 2014) |
| "Rhabdomyolysis is a pathological syndrome caused by skeletal muscle cell damage that affects the integrity of the cellular membrane and leads to the release of toxic intracellular constituents into the bloodstream." | ( Cho, JH; Choi, JY; Huh, S; Jung, HY; Kim, CD; Kim, HK; Kim, KH; Kim, YL; Lee, JH; Park, SC; Park, SH, 2014) |
| "Rhabdomyolysis is a severe condition with an incidence of 28% in hypokalaemic patients." | ( Bach, PT; Raaber, N, 2014) |
| "Rhabdomyolysis is characterized by severe acute muscle injury resulting in muscle pain, weakness, and/or swelling with release of myofiber contents into the bloodstream." | ( Mammen, AL; Nance, JR, 2015) |
| "Rhabdomyolysis is a relatively uncommon, severe complication of anesthesia and surgery in the morbidly obese." | ( Katz, YS; Lehavi, A; Mahajna, A; Sandler, O; Weissman, A, 2015) |
| "Rhabdomyolysis is a rare, but serious complication of statin therapy, and represents the most severe end of the spectrum of statin-induced myotoxicity." | ( Furlong, TJ; Girgis, L; Hayward, CS; Jabbour, A; Keogh, AM; Macdonald, PS; Wang, LW, 2015) |
| "Rhabdomyolysis is a painful and potentially life-threatening injury in which muscle breaks down in response to an insult." | ( DeZee, KJ; Jeter, J; Kennedy, L, 2015) |
| "Liver injury and rhabdomyolysis are common." | ( Camara-Lemarroy, CR; González-González, JG; Monreal-Robles, R; Rodríguez-Gutiérrez, R, 2015) |
| "Rhabdomyolysis is a rare presentation of hypokalemia, although muscle weakness is a well-known manifestation of hypokalemia." | ( Concistrè, A; Fiacco, F; Letizia, C; Marinelli, C; Mitterhofer, AP; Petramala, L; Tinti, F; Umbro, I; Zavatto, A; Zingaretti, V, 2015) |
| "Acute rhabdomyolysis is a rare phenomenon in the emergency setting almost exclusively associated with trauma, drugs, and recent upper respiratory and gastrointestinal infection." | ( Core, SB; Davis, C; Dozier, J; Gagnon, J; Katner, H; Patel, C, 2016) |
| "Rhabdomyolysis is the rapid breakdown of skeletal muscle with release of electrolytes, myoglobin, and other proteins into the circulation." | ( Dawley, C, 2016) |
| "Rhabdomyolysis is a threatening syndrome because it causes the breakdown of skeletal muscle." | ( Cai, G; Chen, X; Geng, X; Hong, Q; Wang, Y; Wu, D; Yang, J; Zhang, G; Zheng, W, 2015) |
| "Rhabdomyolysis is common in very long-chain acyl-CoA dehydrogenase deficiency (VLCADD) and other metabolic myopathies, but its pathogenic basis is poorly understood." | ( de Sain-van der Velden, M; Diekman, EF; Houten, SM; Jeneson, JA; Nievelstein, RA; Schmitz, JP; Takken, T; Van der Pol, WL; van Riel, NA; Visser, G; Wardrop, M, 2016) |
| "Rhabdomyolysis is an acute and potentially fatal syndrome characterized by striated muscle breakdown and subsequent release of muscle cell contents into the systemic circulation." | ( Barker, J; Heard, H, 2016) |
| "Rhabdomyolysis is a rare but well-known complication of statin therapy." | ( Filipovic, M; Müller-Höcker, C; Pietsch, U, 2016) |
| "Rhabdomyolysis is a severe potential adverse drug reaction of statin therapy." | ( Chang, HJ; Hsiao, SH; Hsieh, TH; Kao, SM; Wu, TJ; Yeh, PY, 2016) |
| "Rhabdomyolysis is syndrome characterized by muscle necrosis which causes the release of myoglobin into the bloodstream." | ( Ambapkar, SN; Dwivedy, A; Shetty, N, 2016) |
| "Rhabdomyolysis is a widely recognized yet rare complication in statin use." | ( Frydrychowicz, C; Mueller, W; Pasieka, B; Petros, S; Pierer, M; Weidhase, L, 2017) |
| "Rhabdomyolysis is a relatively rare condition, but its clinical consequences are frequently dramatic in terms of both morbidity and mortality." | ( Bassi, A; Benatti, M; Cervellin, G; Comelli, I; Lippi, G; Sanchis-Gomar, F, 2017) |
| "Rhabdomyolysis is a serious complication of statin treatment." | ( Brateanu, A; Charokopos, A; Muhammad, T; Surbhi, S, 2017) |
| "Rhabdomyolysis is a rare, but known complication to treat-ment with systemic isotretinoin in patients with acne and can lead to severe kidney damage." | ( Paulsrud, C; Schmidt, LS; Stender, IM, 2017) |
| "Rhabdomyolysis is a common and potentially life-threatening syndrome, and acute kidney injury (AKI) is a serious complication." | ( Bjornaas, MA; Jacobsen, D; Vangstad, M, 2019) |
| "Rhabdomyolysis is a known side-effect of statin therapy and combined therapy increases the susceptibility to this complication." | ( Mrotzek, SM; Rassaf, T; Totzeck, M, 2017) |
| "Rhabdomyolysis is a serious syndrome caused by skeletal muscle injury and the subsequent release of breakdown products from damaged muscle cells into systemic circulation." | ( Hase, K; Hayashi, M; Hirahashi, J; Homma, K; Hoshino, T; Kamiya, M; Kurosawa, M; Mayadas, TN; Miyauchi, H; Okubo, K; Sasaki, J; Suzuki, A; Urano, Y; Yamamoto, K, 2018) |
| "Rhabdomyolysis is one of the most severe adverse events, but it is very rare." | ( Muto, Y; Namikawa, K; Ng, W; Nishida, M; Takahashi, A; Tsutsumida, A; Yamazaki, N, 2018) |
| "Rhabdomyolysis is a syndrome characterized by muscle necrosis and the release of intracellular muscle contents into the systemic circulation, which is the most serious and fatal side effect of fenofibrate." | ( Wang, D; Wang, Y, 2018) |
| "Rhabdomyolysis is a potential complication of psychotropic drugs use and may potentially lead to life-threatening complications, such as an acute renal failure." | ( Delacour, H; Keou, S; Lahutte, B; Mennessier, C; Ratnam, C; Saguin, E, 2018) |
| "Rhabdomyolysis is one of the serious side effects of ciprofloxacin (CPFX), a widely used antibacterial drug; and occasionally, acute kidney injury (AKI) occurs." | ( Akai, S; Matsubara, A; Oda, S; Tsuneyama, K; Yokoi, T, 2018) |
| "Rhabdomyolysis is a rare but serious complication of lipid-lowering therapy." | ( Dalugama, C; Kularatne, SAM; Pathirage, M, 2018) |
| "Rhabdomyolysis is a rare but serious complication due to lipid-lowering therapy with statins and fibrates." | ( Dalugama, C; Kularatne, SAM; Pathirage, M, 2018) |
| "Rhabdomyolysis is an emergency requiring rapid diagnosis and suitable aetiological treatment." | ( Biancalana, V; Chanson, JB; Echaniz-Laguna, A; Gaignard, P, 2018) |
| "Rhabdomyolysis is characterized by skeletal muscle injury resulting in the release of intracellular proteins (such as myoglobin) and electrolytes into the blood circulation, which cause acute kidney injury, myoglobinuria and electrolyte imbalances." | ( Hu, HY; Pan, CH; Wei, SY, 2018) |
| "Rhabdomyolysis is a relatively rare, but potentially serious complication of various diseases." | ( Anand, JS; Gil, D; Kała, M; Lechowicz, W; Waldman, W, 2018) |
| "Heat stress and rhabdomyolysis are major risk factors for the occurrence of repeated acute kidney injury in workers exposed to heat and strenuous work." | ( Blas-Marron, MG; García-Arroyo, FE; Glaser, J; Gonzaga, G; Johnson, RJ; Madero, M; Muñoz-Jimenez, I; Osorio-Alonso, H; Roncal-Jiménez, CA; Sánchez-Lozada, LG; Silverio, O; Tapia, E; Weiss, I, 2018) |
| "Rhabdomyolysis is a potentially life-threatening syndrome and is a rare complication in patients with acute leukemia." | ( Le, Y; Li, H; Liu, Z; Long, Y; Wan, C, 2018) |
| "Rhabdomyolysis is characterized by elevation of plasma creatine phosphokinase (CPK) level, and multiple organ disorders, especially renal failure, as well as approximately 50% of acquired rhabdomyolysis are caused by pharmaceuticals." | ( Akai, S; Matsubara, A; Oda, S; Watanabe, K; Yokoi, T, 2019) |
| "Exertional rhabdomyolysis is a common condition with potentially life-threatening consequences; early recognition can prevent severe downstream complications." | ( Andreae, MC; Fernando, DB; McVane, BA; Strayer, RJ, 2019) |
| "Rhabdomyolysis is a serious and life-threatening condition which has many established causes including endocrine disturbances." | ( Kennedy, L; Nagiah, S, 2019) |
| "Rhabdomyolysis is a relatively common and life-threatening disease that is sometimes complicated by acute kidney injury (AKI)." | ( Kikuchi, H; Kojima, M; Koutoku, H; Nagata, H; Oda, Y; Watanabe, Y, 2019) |
| "Rhabdomyolysis is a known risk associated with statin therapy but has seldom been described with fluoroquinolone use." | ( Bouchard, J; De La Pena, N; Oleksiuk, LM, 2019) |
| "Rhabdomyolysis is a potentially life-threatening clinical syndrome caused by skeletal muscle injury with the release of muscle cell contents into the circulation." | ( Hirota, N; Komatsu, T; Ohara, N; Ozawa, T; Sone, H; Tani, T; Terajima, K; Yoneoka, Y, 2019) |
| "Rhabdomyolysis is diagnosed based on the levels of blood biomarkers such as creatine kinase (CK), but the use of CK levels to predict long-term renal function remains controversial." | ( Chen, CH; Tsai, JL; Tsai, SF, 2020) |
| "Rhabdomyolysis is a severe situation and potentially fatal." | ( Cervilla Sáez de Tejada, E; Díaz Alcázar, MDM; Ruiz Escolano, E, 2020) |
| "Rhabdomyolysis is a rare and complex condition that involves injury of the skeletal muscle fibres, resulting in the release of substances such as creatine kinase and myoglobin." | ( Fenwick, R; O'Carroll, C, 2020) |
| "Rhabdomyolysis is defined by disintegration of skeletal muscle fibres." | ( Klein, B; Silberbauer, C, 2021) |
| "Those with rhabdomyolysis are at significantly higher risk of kidney injury and have a longer length of hospital stay." | ( Dargan, PI; Dines, AM; Giraudon, I; Heyerdahl, F; Hovda, KE; Kabata, PM; Sein Anand, J; Waldman, W; Wood, DM; Yates, C, 2021) |
| "Rhabdomyolysis is defined as a syndrome consisting of muscle necrosis and the release of intracellular muscle components into the bloodstream." | ( Chaudry, S; Dong, T; Egoryan, G; Ozcekirdek, E; Ozen, E; Rodriguez-Nava, G; Yadav, K, 2021) |
| "Rhabdomyolysis is the acute breakdown of skeletal myofibres in response to an initiating factor, most commonly toxins and over exertion." | ( Auranen, M; Aydin, HI; Brady, S; Bratkovic, D; Bugiardini, E; Cabrera-Serrano, M; Caccavelli, L; Capiod, T; Ceylaner, S; Davis, MR; de Lonlay, P; Drewes, S; Folland, C; Forrest, ARR; Goullee, H; Hilton-Jones, D; Houlden, H; Johari, M; Jokela, M; Kelly, A; Laing, NG; Madrange, M; Manton, N; McCombe, P; Merve, A; O'Gorman, C; Phillips, L; Quinlivan, R; Ravenscroft, G; Robertson, T; Savarese, M; Scalco, R; Taylor, RL; Tyynismaa, H; Udd, B; Vihola, A; Vockley, J; Ylikallio, E, 2022) |
| "Rhabdomyolysis is more common in BACM due to the influenza A virus." | ( Cicek, C; Keskin, G; Saz, EU; Turan, C; Yurtseven, A, 2022) |
| "Rhabdomyolysis is a syndrome of rapid skeletal muscle breakdown as a result of direct or indirect skeletal muscle injury." | ( Holwerda, TJ; Yildiz, RLW, 2022) |
| "Rhabdomyolysis is a series of symptoms caused by the dissolution of striped muscle, and acute kidney injury (AKI) is a potential complication of severe rhabdomyolysis." | ( Jiejun, W; Lisha, Z; Niansong, W; Qin, X; Yuqiang, C, 2022) |
| "Rhabdomyolysis is a serious and potentially life threatening condition that can be caused by drugs." | ( Cui, W; Li, C; Lu, X; Teng, W; Wang, W, 2022) |
| "BACKGROUND Rhabdomyolysis is a condition in which intracellular components are released into the blood and urine." | ( Hirose, N; Inoue, J; Ishii, J; Koshioka, S; Kunishima, H; Kurata, T; Matsuura, M; Nagumo, F; Sada, Y; Samura, M; Takada, K; Tanikawa, K; Uchida, M, 2022) |
| "Rhabdomyolysis is a life-threatening condition." | ( Deng, Y; Sun, T; Wu, D; Zhang, D, 2022) |
| "Rhabdomyolysis is a condition in which muscle breaks down potentially leading to renal dysfunction, and often occurs secondary to a precipitating factor." | ( Abbara, A; Bawor, M; Comninos, AN; Rozewicz, R; Sairam, S; Viegas, S, 2022) |
| "The incidence of rhabdomyolysis is relatively low, but the mortality rate is extremely high once it occurs." | ( He, YP; Lu, ZX; Song, YX; Wang, C; Wang, J; Wang, JN, 2022) |
| "Rhabdomyolysis is the collapse of damaged skeletal muscle and the leakage of muscle-cell contents, such as electrolytes, myoglobin, and other sarcoplasmic proteins, into the circulation." | ( Ikebe, S; Katsuragi, N; Koibuchi, N; Morishita, R; Muratsu, J; Rakugi, H; Sanada, F; Shibata, K; Taniyama, Y; Tsunetoshi, Y, 2022) |
| "Rhabdomyolysis is a syndrome resulting from striated muscular breakdown, which may occur due to drug therapy with agents such as selective serotonin reuptake inhibitors (SSRIs)." | ( Cui, Z; Gong, W; Li, J; Lu, Y; Zhang, F, 2023) |
| "Rhabdomyolysis is a syndrome resulting from striated muscular breakdown, which may occur due to drug therapy with agents such as selective serotonin reuptake inhibitors (SSRIs)." | ( Cui, Z; Gong, W; Li, J; Lu, Y; Zhang, F, 2023) |
| "Rhabdomyolysis is a syndrome characterized by muscle necrosis and the release of muscle cell contents into blood circulation." | ( Chen, L; Guo, C; Huang, Z; Liu, Y, 2023) |
| "Rhabdomyolysis is a syndrome characterized by muscle necrosis and the release of muscle cell contents into blood circulation." | ( Chen, L; Guo, C; Huang, Z; Liu, Y, 2023) |
| "Rhabdomyolysis is a well-documented side effect of daptomycin and is associated with hyperuricemia." | ( Abdelnabi, M; Leelaviwat, N; Liao, ED; Motamedi, S; Nugent, K; Pangkanon, W, 2023) |
| "Rhabdomyolysis is characterized by muscle damage and leads to acute kidney injury (AKI)." | ( Bernardo, DRD; Canale, D; de Bragança, AC; Nascimento, MM; Seguro, AC; Shimizu, MHM; Volpini, RA, 2023) |
| "Rhabdomyolysis is a syndrome that presents injury and necrosis of muscle cells leading to the release of intracellular material to the circulatory system." | ( Castro, JBP; Coutinho, VFF; Dantas, GHM; Marcos-Pardo, PJ; Oliveira, ALB; Sá Freire, FC; Souza Vale, RG, 2022) |
| "Rhabdomyolysis is a serious adverse drug reaction of statins." | ( Montastruc, JL, 2023) |
| "Rhabdomyolysis is a syndrome potentially fatal and has been associated with selective serotonin reuptake inhibitors (SSRIs) treatment in a few case reports." | ( Cai, W; Jiang, D; Liang, H; Lin, Q; Lin, Y; Wang, Y, 2023) |
| "Rhabdomyolysis is a rare serious side effect of antipsychotic medication use." | ( Apa, H; Kutlu, A; Songür, ÇY, 2023) |
| "Rhabdomyolysis is a potentially life-threatening condition induced by diverse mechanisms including drugs and toxins." | ( Akbari, S; Amanollahi, A; Babeveynezhad, T; Besharatpour, M; Etemad, K; Jorjani, G; Mehrabi, Y; Salehian, E; Sedighi, M; Shadnia, S; Taheri, M, 2023) |